💬 There’s still capital out there – it’s just coming from new directions.
Our CEO, Richard Marshall CBE, shares his insights on the evolving biotech funding landscape and where companies like Juvenescence are finding opportunity amid the VC pullback by forging strategic partnerships in markets that value deep R&D expertise.
👇 Read the insightful piece from Jo Shorthouse in In Vivo:
🔗 https://insights.citeline.com/in-vivo/growth/when-vc-steps-back-finding-alternative-biotech-funding-4UN5IYJEUZD2XPLYIZ7RR7YVQY/
hashtagBiotech hashtagVentureCapital hashtagLifeSciences hashtagAlternativeFunding hashtagJuvenescence hashtagInVivo hashtagLongevity